Clinical trial

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

NCT06775093

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention GLP-1 receptor agonist Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Metformin Normalized identity: metforminView linked drug · Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention healthy lifestyle education Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-03-01

PhaseNA

Conditions

Polycystic Ovary Syndromeverified · MONDO: polycystic ovary syndrome

Obesityverified · MONDO: obesity disorder

Infertility, Femalecandidate · MONDO: female infertility

Interventions

GLP-1 receptor agonistDRUG

MetforminDRUG · verified · RxNorm: metformin

healthy lifestyle educationBEHAVIORAL

Sponsors & collaborators

Peking University Third Hospitallead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06775093 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.